Soluble urokinase‐type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra‐bone marrow involvement in multiple myeloma patients
- 18 March 2003
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 120 (6) , 953-959
- https://doi.org/10.1046/j.1365-2141.2003.04176.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 32 references indexed in Scilit:
- Urokinase-Type Plasminogen Activator Binding to Its Receptor Stimulates Tumor Cell Migration by Enhancing Integrin-Mediated Signal TransductionExperimental Cell Research, 1999
- Role and Localization of Urokinase Receptor in the Formation of New Microvascular Structures in Fibrin MatricesThe American Journal of Pathology, 1999
- The Role of the Plasminogen System in Bone Resorption In VitroJournal of Bone and Mineral Research, 1999
- Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationNature Genetics, 1997
- Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPARThe International Journal of Cell Cloning, 1997
- uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?Immunology Today, 1997
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- Detection of vitronectin in mineralized bone matrix.Journal of Histochemistry & Cytochemistry, 1996
- Plasminogen activator dependent pathways inthe dissemination of human tumor cells in the chick embryoCell, 1988
- Endogenous Activation of Latent Collagenase by Rheumatoid Synovial CellsNew England Journal of Medicine, 1977